{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T06:25:18Z","timestamp":1791872718907,"version":"4.3.4"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,6,6]],"date-time":"2008-06-06T00:00:00Z","timestamp":1212710400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2008,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Despite extensive research, the five-year survival rate of oral squamous cell carcinoma (OSCC) patients has not improved. Effective treatment of OSCC requires the identification of molecular targets and signaling pathways to design appropriate therapeutic strategies. Several genes from the mTOR signaling pathway are known to be dysregulated in a wide spectrum of cancers. However, not much is known about the involvement of this pathway in tumorigenesis of OSCC. We therefore investigated the role of the tumor suppressor genes, <jats:italic>TSC1<\/jats:italic> and <jats:italic>TSC2<\/jats:italic>, and other members of this pathway in tumorigenesis of OSCC.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Expression of genes at the RNA and protein levels was examined by semi-quantitative RT-PCR and western blot analyses, respectively. Loss of heterozygosity was studied using matched blood and tumor DNA samples and microsatellite markers from the <jats:italic>TSC1<\/jats:italic>, <jats:italic>TSC2<\/jats:italic> and <jats:italic>PTEN<\/jats:italic> candidate regions. The effect of promoter methylation on TSC gene expression was studied by treating cells with methyltransferase inhibitor 5-azacytidine. Methylation status of the <jats:italic>TSC2<\/jats:italic> promoter in tissue samples was examined by combined bisulfite restriction analysis (COBRA).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The semi-quantitative RT-PCR analysis showed downregulation of <jats:italic>TSC1<\/jats:italic>, <jats:italic>TSC2<\/jats:italic>, <jats:italic>EIF4EBP1<\/jats:italic> and <jats:italic>PTEN<\/jats:italic>, and upregulation of <jats:italic>PIK3C2A<\/jats:italic>, <jats:italic>AKT1<\/jats:italic>, <jats:italic>PDPK1<\/jats:italic>, <jats:italic>RHEB<\/jats:italic>, <jats:italic>FRAP1<\/jats:italic>, <jats:italic>RPS6KB1<\/jats:italic>, <jats:italic>EIF4E<\/jats:italic> and <jats:italic>RPS6<\/jats:italic> in tumors. A similar observation was made for AKT1 and RPS6KB1 expression in tumors at the protein level. Investigation of the mechanism of downregulation of TSC genes identified LOH in 36.96% and 39.13% of the tumors at the TSC1 and TSC2 loci, respectively. No mutation was found in TSC genes. A low LOH rate of 13% was observed at the PTEN locus. Treatment of an OSCC cell line with the methyltransferase inhibitor 5-azacytidine showed a significant increase in the expression of TSC genes, suggesting methylation of their promoters. However, the 5-azacytidine treatment of non-OSCC HeLa cells showed a significant increase in the expression of the <jats:italic>TSC2<\/jats:italic> gene only. In order to confirm the results in patient tumor samples, the methylation status of the <jats:italic>TSC2<\/jats:italic> gene promoter was examined by COBRA. The results suggested promoter hypermethylation as an important mechanism for its downregulation. No correlation was found between the presence or absence of LOH at the TSC1 and TSC2 loci in 50 primary tumors to their clinicopathological variables such as age, sex, T classification, stage, grade, histology, tobacco habits and lymph node metastasis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Our study suggests the involvement of TSC genes and other members of the mTOR signaling pathway in the pathogenesis of OSCC. LOH and promoter methylation are two important mechanisms for downregulation of TSC genes. We suggest that known inhibitors of this pathway could be evaluated for the treatment of OSCC.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2407-8-163","type":"journal-article","created":{"date-parts":[[2008,6,6]],"date-time":"2008-06-06T18:13:37Z","timestamp":1212776017000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":82,"title":["Involvement of TSC genes and differential expression of other members of the mTOR signaling pathway in oral squamous cell carcinoma"],"prefix":"10.1186","volume":"8","author":[{"given":"Sanjukta","family":"Chakraborty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SM Azeem","family":"Mohiyuddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KS","family":"Gopinath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,6,6]]},"reference":[{"key":"1101_CR1","first-page":"1","volume-title":"Contemporary issues in oral cancer","author":"PN Notani","year":"2000","unstructured":"Notani PN: Epidemiology and prevention of head and neck cancer: a global view. Contemporary issues in oral cancer. Edited by: Saranath D. 2000, New Delhi: Oxford University Press, 1-29."},{"key":"1101_CR2","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/S1368-8375(03)00098-8","volume":"39","author":"J Sudbo","year":"2003","unstructured":"Sudbo J, Bryne M, Mao L, Lotan R, Reith A, Kildal W, Davidson B, Soland TM, Lippman SM: Molecular based treatment of oral cancer. Oral Oncol. 2003, 39: 749-758. 10.1016\/S1368-8375(03)00098-8.","journal-title":"Oral Oncol"},{"key":"1101_CR3","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/mc.20048","volume":"42","author":"S Arora","year":"2005","unstructured":"Arora S, Matta A, Shukla NK, Deo SV, Ralhan R: Identification of differentially expressed genes in oral squamous cell carcinoma. Mol Carcinog. 2005, 42: 97-108. 10.1002\/mc.20048.","journal-title":"Mol Carcinog"},{"key":"1101_CR4","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1042\/bst0310573","volume":"31","author":"BD Manning","year":"2003","unstructured":"Manning BD, Cantley LC: United at last: the tuberous sclerosis complex gene products connect the phosphoinositide 3-kinase\/Akt pathway to mammalian target of rapamycin (mTOR) signaling. Biochem Soc Trans. 2003, 31: 573-578. 10.1042\/BST0310573.","journal-title":"Biochem Soc Trans"},{"key":"1101_CR5","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/nrc839","volume":"2","author":"I Vivanco","year":"2002","unstructured":"Vivanco I, Sawyers CL: The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat Rev Cancer. 2002, 2: 489-501. 10.1038\/nrc839.","journal-title":"Nat Rev Cancer"},{"key":"1101_CR6","first-page":"997","volume":"21","author":"KH Shin","year":"2002","unstructured":"Shin KH, Kim JM, Rho KS, Park KH, Oh JE, Min BM: Inactivation of the PTEN gene by mutation, exonic deletion, and loss of transcript in human oral squamous cell carcinomas. Int J Oncol. 2002, 21: 997-1001.","journal-title":"Int J Oncol"},{"key":"1101_CR7","first-page":"2300","volume":"9","author":"CL Estilo","year":"2003","unstructured":"Estilo CL, O-Charoenrat P, Ngai I, Patel SG, Reddy PG, Dao S, Shaha AR, Kraus DH, Boyle JO, Wong RJ, Pfister DG, Huryn JM, Zlotolow IM, Shah JP, Singh B: The role of novel oncogenes squamous cell carcinoma-related oncogene and phosphatidylinositol 3-kinase p110alpha in squamous cell carcinoma of the oral tongue. Clin Cancer Res. 2003, 9: 2300-2306.","journal-title":"Clin Cancer Res"},{"key":"1101_CR8","doi-asserted-by":"publisher","first-page":"9953","DOI":"10.1158\/0008-5472.CAN-05-0921","volume":"65","author":"P Amornphimoltham","year":"2005","unstructured":"Amornphimoltham P, Patel V, Sodhi A, Nikitakis NG, Sauk JJ, Sausville EA, Molinolo AA, Gutkind JS: Mammalian target of rapamycin, a molecular target in squamous cell carcinomas of the head and neck. Cancer Res. 2005, 65: 9953-9961. 10.1158\/0008-5472.CAN-05-0921.","journal-title":"Cancer Res"},{"key":"1101_CR9","doi-asserted-by":"publisher","first-page":"5820","DOI":"10.1158\/1078-0432.CCR-03-0483","volume":"10","author":"CA Nathan","year":"2004","unstructured":"Nathan CA, Amirghahari N, Abreo F, Rong X, Caldito G, Jones ML, Zhou H, Smith M, Kimberly D, Glass J: Overexpressed eIF4E is functionally active in surgical margins of head and neck cancer patients via activation of the Akt\/mammalian target of rapamycin pathway. Clin Cancer Res. 2004, 10: 5820-5827. 10.1158\/1078-0432.CCR-03-0483.","journal-title":"Clin Cancer Res"},{"key":"1101_CR10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1476-4598-5-3","volume":"5","author":"C Hebert","year":"2006","unstructured":"Hebert C, Norris K, Parashar P, Ord RA, Nikitakis NG, Sauk JJ: Hypoxia-inducible factor-1\u03b1 polymorphisms and TSC1\/2 mutations are complementary in head and neck cancers. Mol Cancer. 2006, 5: 3-10.1186\/1476-4598-5-3.","journal-title":"Mol Cancer"},{"key":"1101_CR11","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1002\/(SICI)1097-0142(19971101)80:9<1803::AID-CNCR16>3.0.CO;2-9","volume":"80","author":"LH Sobin","year":"1997","unstructured":"Sobin LH, Fleming ID: TNM classification of malignant tumors, fifth edition. Union Internationale Centre le Cancer and the American Joint Committee on Cancer. Cancer. 1997, 80: 1803-1804. 10.1002\/(SICI)1097-0142(19971101)80:9<1803::AID-CNCR16>3.0.CO;2-9.","journal-title":"Cancer"},{"key":"1101_CR12","volume-title":"An introduction to biostatistics, a manual for students in health sciences","author":"PSSS Rao","year":"2003","unstructured":"Rao PSSS, Richard J: An introduction to biostatistics, a manual for students in health sciences. 2003, New Delhi: Prentice-Hall of India Private Ltd"},{"key":"1101_CR13","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.ygeno.2007.05.002","volume":"90","author":"S Chakraborty","year":"2007","unstructured":"Chakraborty S, Khare S, Dorairaj SK, Prabhakaran VC, Prakash DR, Kumar A: Identification of genes associated with tumorigenesis of retinoblastoma by microarray analysi. Genomics. 2007, 90: 344-353. 10.1016\/j.ygeno.2007.05.002.","journal-title":"Genomics"},{"key":"1101_CR14","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/0888-7543(89)90129-8","volume":"5","author":"M Orita","year":"1989","unstructured":"Orita M, Suzuki Y, Sekia T, Hayashi K: Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics. 1989, 5: 874-879. 10.1016\/0888-7543(89)90129-8.","journal-title":"Genomics"},{"key":"1101_CR15","first-page":"173","volume":"103","author":"A Kumar","year":"1998","unstructured":"Kumar A, Becker LA, Depinet TW, Haren JM, Kurtz CL, Robin NH, Cassidy SB, Wolff DJ, Schwartz S: Molecular characterization and delineation of subtle deletions in de novo \"balanced\" chromosomal rearrangements. Hum Genet. 1998, 103: 173-178.","journal-title":"Hum Genet"},{"key":"1101_CR16","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1093\/nar\/25.12.2532","volume":"25","author":"Z Xiong","year":"1997","unstructured":"Xiong Z, Laird PW: COBRA: a sensitive and quantitative DNA methylation assay. Nucl Acids Res. 1997, 25: 2532-2534. 10.1093\/nar\/25.12.2532.","journal-title":"Nucl Acids Res"},{"key":"1101_CR17","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1093\/bioinformatics\/18.11.1427","volume":"18","author":"LC Li","year":"2002","unstructured":"Li LC, Dahiya R: MethPrimer: designing primers for methylation PCRs. Bioinformatics. 2002, 18: 1427-1431. 10.1093\/bioinformatics\/18.11.1427. [http:\/\/www.urogene.org\/methprimer]","journal-title":"Bioinformatics"},{"key":"1101_CR18","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1007\/s003359900502","volume":"8","author":"T Kobayashi","year":"1997","unstructured":"Kobayashi T, Urakami S, Cheadle JP, Aspinwall R, Harris P, Sampson JR, Hino O: Identification of a leader exon and a core promoter for the rat tuberous sclerosis 2 (Tsc2) gene and structural comparison with the human homolog. Mamm Genome. 1997, 8: 554-558. 10.1007\/s003359900502.","journal-title":"Mamm Genome"},{"key":"1101_CR19","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0378-1119(03)00821-7","volume":"320","author":"M Ali","year":"2003","unstructured":"Ali M, Girimaji SC, Kumar A: Identification of a core promoter and a novel isoform of the human TSC1 gene transcript and structural comparison with mouse homolog. Gene. 2003, 320: 145-154. 10.1016\/S0378-1119(03)00821-7.","journal-title":"Gene"},{"key":"1101_CR20","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1007\/s004390000390","volume":"107","author":"L Parry","year":"2000","unstructured":"Parry L, Maynard JH, Patel A, Hodges AK, von Deimling A, Sampson JR, Cheadle JP: Molecular analysis of the TSC1 and TSC2 tumour suppressor genes in sporadic glial and glioneuronal tumours. Hum Genet. 2000, 107: 350-356. 10.1007\/s004390000390.","journal-title":"Hum Genet"},{"key":"1101_CR21","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1054\/bjoc.2001.2072","volume":"85","author":"L Parry","year":"2001","unstructured":"Parry L, Maynard JH, Patel A, Clifford SC, Morrissey C, Maher ER, Cheadle JP, Sampson JR: Analysis of the TSC1 and TSC2 genes in sporadic renal cell carcinomas. Br J Cancer. 2001, 85: 1226-1230. 10.1054\/bjoc.2001.2072.","journal-title":"Br J Cancer"},{"key":"1101_CR22","first-page":"7652","volume":"63","author":"MA Knowles","year":"2003","unstructured":"Knowles MA, Habuchi T, Kennedy W, Cuthbert-Heavens D: Mutation spectrum of the 9q34 tuberous sclerosis gene TSC1 in transitional cell carcinoma of the bladder. Cancer Res. 2003, 63: 7652-7656.","journal-title":"Cancer Res"},{"key":"1101_CR23","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1042\/bst0310597","volume":"3","author":"MA Knowles","year":"2003","unstructured":"Knowles MA, Hornigold N, Pitt E: Tuberous sclerosis complex (TSC) gene involvement in sporadic tumours. Biochem Soc Trans. 2003, 3: 597-602. 10.1042\/BST0310597.","journal-title":"Biochem Soc Trans"},{"key":"1101_CR24","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1016\/j.ejca.2005.03.023","volume":"41","author":"WG Jiang","year":"2005","unstructured":"Jiang WG, Sampson J, Martin TA, Lee-Jones L, Watkins G, Douglas-Jones A, Mokbel K, Mansel RE: Tuberin and hamartin are aberrantly expressed and linked to clinical outcome in human breast cancer: the role of promoter methylation of TSC genes. Eur J Cancer. 2005, 41: 1628-1636. 10.1016\/j.ejca.2005.03.023.","journal-title":"Eur J Cancer"},{"key":"1101_CR25","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.surg.2005.06.028","volume":"138","author":"K Kataoka","year":"2005","unstructured":"Kataoka K, Fujimoto K, Ito D, Koizumi M, Toyoda E, Mori T, Kami K, Doi R: Expression and prognostic value of tuberous sclerosis complex 2 gene product tuberin in human pancreatic cancer. Surgery. 2005, 138: 450-455. 10.1016\/j.surg.2005.06.028.","journal-title":"Surgery"},{"key":"1101_CR26","doi-asserted-by":"publisher","first-page":"9432","DOI":"10.1038\/sj.onc.1208092","volume":"23","author":"QN Vo","year":"2004","unstructured":"Vo QN, Kim WJ, Cvitanovic L, Boudreau DA, Ginzinger DG, Brown KD: The ATM gene is a target for epigenetic silencing in locally advanced breast cancer. Oncogene. 2004, 23: 9432-9437. 10.1038\/sj.onc.1208092.","journal-title":"Oncogene"},{"key":"1101_CR27","first-page":"2890","volume":"8","author":"Q Yang","year":"2002","unstructured":"Yang Q, Nakamura M, Nakamura Y, Yoshimura G, Suzuma T, Umemura T, Shimizu Y, Mori I, Sakurai T, Kakudo K: Two-hit inactivation of FHIT by loss of heterozygosity and hypermethylation in breast cancer. Clin Cancer Res. 2002, 8: 2890-2893.","journal-title":"Clin Cancer Res"},{"key":"1101_CR28","first-page":"3034","volume":"9","author":"S Toyooka","year":"2003","unstructured":"Toyooka S, Toyooka KO, Miyajima K, Reddy JL, Toyota M, Sathyanarayana UG, Padar A, Tockman MS, Lam S, Shivapurkar N, Gazdar AF: Epigenetic down-regulation of death-associated protein kinase in lung cancers. Clin Cancer Res. 2003, 9: 3034-3041.","journal-title":"Clin Cancer Res"},{"key":"1101_CR29","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/sj.bjc.6602970","volume":"94","author":"B Karakas","year":"2006","unstructured":"Karakas B, Bachman KE, Park BH: Mutation of the PIK3CA oncogene in human cancers. Br J Cancer. 2006, 94: 455-459. 10.1038\/sj.bjc.6602970.","journal-title":"Br J Cancer"},{"key":"1101_CR30","doi-asserted-by":"publisher","first-page":"7455","DOI":"10.1038\/sj.onc.1209085","volume":"24","author":"DA Altomare","year":"2005","unstructured":"Altomare DA, Testa JR: Perturbations of the AKT signaling pathway in human cancer. Oncogene. 2005, 24: 7455-7464. 10.1038\/sj.onc.1209085.","journal-title":"Oncogene"},{"key":"1101_CR31","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ctrv.2003.07.007","volume":"30","author":"JA Fresno-Vara","year":"2004","unstructured":"Fresno-Vara JA, Casado E, de Castro J, Cejas P, Belda-Iniesta C, Gonzalez-Baron M: PI3K\/Akt signalling pathway and cancer. Cancer Treat Rev. 2004, 30: 193-204. 10.1016\/j.ctrv.2003.07.007.","journal-title":"Cancer Treat Rev"},{"key":"1101_CR32","first-page":"M21","volume":"1470","author":"F Vazquez","year":"2000","unstructured":"Vazquez F, Sellers WR: The PTEN tumor suppressor protein: an antagonist of phosphoinositide 3-kinase signaling. Biochem Biophys Acta. 2000, 1470: M21-35.","journal-title":"Biochem Biophys Acta"},{"key":"1101_CR33","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1034\/j.1600-0714.2002.310504.x","volume":"31","author":"A Mavros","year":"2002","unstructured":"Mavros A, Hahn M, Wieland I, Koy S, Koufaki ON, Strelocke K, Koch R, Haroske G, Schackert HK, Eckelt U: Infrequent genetic alterations of the tumor suppressor gene PTEN\/MMAC1 in squamous cell carcinoma of the oral cavity. J Oral Pathol Med. 2002, 31: 270-276. 10.1034\/j.1600-0714.2002.310504.x.","journal-title":"J Oral Pathol Med"},{"key":"1101_CR34","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1586\/14737140.4.4.691","volume":"4","author":"DA Foster","year":"2004","unstructured":"Foster DA: Targeting mTOR-mediated survival signals in anticancer therapeutic strategies. Expert Rev Anticancer Ther. 2004, 4: 691-701. 10.1586\/14737140.4.4.691.","journal-title":"Expert Rev Anticancer Ther"},{"key":"1101_CR35","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S1357-2725(98)00132-0","volume":"31","author":"A De Benedetti","year":"1999","unstructured":"De Benedetti A, Harris AL: eIF4E expression in tumors: its possible role in progression of malignancies. Int J Biochem Cell Biol. 1999, 31: 59-72. 10.1016\/S1357-2725(98)00132-0.","journal-title":"Int J Biochem Cell Biol"},{"key":"1101_CR36","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1042\/bst0310587","volume":"31","author":"M Nellist","year":"2003","unstructured":"Nellist M, Goedbloed MA, Halley DJ: Regulation of tuberous sclerosis complex (TSC) function by 14-3-3 proteins. Biochem Soc Trans. 2003, 31: 587-591. 10.1042\/BST0310587.","journal-title":"Biochem Soc Trans"},{"key":"1101_CR37","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/1471-2407-7-169","volume":"7","author":"A Matta","year":"2007","unstructured":"Matta A, Bahadur S, Duggal R, Gupta SD, Ralhan R: Over-expression of 14-3-3zeta is an early event in oral cancer. BMC Cancer. 2007, 7: 169-10.1186\/1471-2407-7-169.","journal-title":"BMC Cancer"},{"key":"1101_CR38","first-page":"2072","volume":"62","author":"M Gasco","year":"2002","unstructured":"Gasco M, Bell AK, Heath V, Sullivan A, Smith P, Hiller L, Yulug I, Numico G, Merlano M, Farrell PJ, Tavassoli M, Gusterson B, Crook T: Epigenetic inactivation of 14-3-3 sigma in oral carcinoma: association with p16(INK4a) silencing and human papillomavirus negativity. Cancer Res. 2002, 62: 2072-2076.","journal-title":"Cancer Res"},{"key":"1101_CR39","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1158\/0008-5472.CAN-06-2449","volume":"67","author":"CO Nathan","year":"2007","unstructured":"Nathan CO, Amirghahari N, Rong X, Giordano T, Sibley D, Nordberg M, Glass J, Agarwal A, Caldito G: Mammalian target of rapamycin inhibitors as possible adjuvant therapy for microscopic residual disease in head and neck squamous cell cancer. Cancer Res. 2007, 67: 2160-2168. 10.1158\/0008-5472.CAN-06-2449.","journal-title":"Cancer Res"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-8-163.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-8-163\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-8-163","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-8-163.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T02:36:37Z","timestamp":1630463797000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-8-163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6,6]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["1101"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-8-163","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,6,6]]},"assertion":[{"value":"10 January 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2008","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2008","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"163"}}